Cardiac imaging approaches to evaluate drug-induced myocardial dysfunction
- 31 December 2012
- journal article
- review article
- Published by Elsevier BV in American Heart Journal
- Vol. 164 (6), 846-855
- https://doi.org/10.1016/j.ahj.2012.09.001
Abstract
No abstract availableThis publication has 77 references indexed in Scilit:
- Cardiovascular MRI in clinical trials: expanded applications through novel surrogate endpointsHeart, 2011
- Echocardiographic Speckle-Tracking Based Strain Imaging for Rapid Cardiovascular Phenotyping in MiceCirculation Research, 2011
- Emerging MRI Methods in Translational Cardiovascular ResearchJournal of Cardiovascular Translational Research, 2011
- Novel Approach to Early Detection of Doxorubicin Cardiotoxicity by Gadolinium-Enhanced Cardiovascular Magnetic Resonance Imaging in an Experimental ModelCirculation: Cardiovascular Imaging, 2010
- Reduced in vivo high-energy phosphates precede Adriamycin-induced cardiac dysfunctionAmerican Journal of Physiology-Heart and Circulatory Physiology, 2010
- Cardiotoxicity of the Anticancer Therapeutic Agent BortezomibThe American Journal of Pathology, 2010
- Delayed contrast enhancement cardiac magnetic resonance imaging in trastuzumab induced cardiomyopathyJournal of Cardiovascular Magnetic Resonance, 2008
- Cardiotoxicity associated with tyrosine kinase inhibitor sunitinibThe Lancet, 2007
- Clinical heart failure in a cohort of children treated with anthracyclines: A long-term follow-up studyEuropean Journal of Cancer, 2006
- Detection of Early Anthracycline Cardiotoxicity by Monitoring the Peak Filling RateAmerican Journal of Clinical Oncology, 1993